Jama Connect
Jama Connect®, a product development platform, uniquely creates Living Requirements™. This digital thread is created through siloed, test, and risk activities to provide end to end compliance, risk mitigation, process improvement, and compliance. Companies creating complex products, systems, and software can now define, align, and execute on what they need. This reduces the time and effort required to prove compliance and saves on rework. You can be sure of success by choosing a solution that is easy-to-use, flexible, and offers support and services that are adoption-oriented.
Learn more
TrustInSoft Analyzer
TrustInSoft commercializes a source code analyzer called TrustInSoft Analyzer, which analyzes C and C++ code and mathematically guarantees the absence of defects, immunity of software components to the most common security flaws, and compliance with a specification. The technology is recognized by U.S. federal agency the National Institute of Standards and Technology (NIST), and was the first in the world to meet NIST’s SATE V Ockham Criteria for high quality software.
The key differentiator for TrustInSoft Analyzer is its use of mathematical approaches called formal methods, which allow for an exhaustive analysis to find all the vulnerabilities or runtime errors and only raises true alarms.
Companies who use TrustInSoft Analyzer reduce their verification costs by 4, efforts in bug detection by 40, and obtain an irrefutable proof that their software is safe and secure.
The experts at TrustInSoft can also assist clients in training, support and additional services.
Learn more
Healnet
Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.
Learn more
Discngine Assay
Discngine Assay serves as a comprehensive laboratory informatics platform that unifies all stages of plate-based assays into a streamlined, compliant, and effective workflow, proving to be a vital resource for screening research laboratories. This platform empowers researchers to optimize their entire High Throughput Screening process, encompassing everything from managing samples and analyzing assay data to data storage and qualifying liquid handling instruments. With its user-friendly interface and powerful API, Discngine Assay integrates effortlessly with laboratory equipment and the existing IT infrastructure, facilitating effective data collection and processing. Tailored to expedite the discovery of new molecules, it meets the requirements of the pharmaceutical, biotech, and contract research organization sectors, thereby promoting collaboration and fostering innovation within life sciences research. Furthermore, its ability to adapt to various laboratory environments makes it a versatile solution for evolving research demands.
Learn more
